Tag
Aarti Pharmalabs Limited
2 articles
Aarti Pharmalabs FY26 PAT Declines 31.5% YoY
Aarti Pharmalabs reported standalone FY26 PAT of ₹1,762 Mn, a 31.5% YoY decline due to forex losses and higher finance costs.
The company outlined a significant capex plan including ₹400 Cr Atali proj
Aarti Pharmalabs 7th AGM Approves Rs 2 Dividend
Aarti Pharmalabs held its 7th Annual General Meeting on September 22, 2026, adopting FY26 financial statements.
Declared final dividend of ₹2 per equity share of face value ₹5 for financial year ended